Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies
US11542295B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 27, 2018 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Dec 24, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 20-hydroxyecdysone and the derivatives thereof, for use in the treatment of genetic myopathies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.